Reside video webcast on Monday, June 17th at 12:00 PM ET
Carlsbad, CA, June 10, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (Palisade or the Firm), biopharmaceutical firm targeted on creating and advancing novel therapeutics for sufferers residing with autoimmune, inflammatory, and fibrotic ailments, as we speak introduced that it’ll current on the Digital Investor Pitch Convention on June 17, 2024 at 12:00 PM ET.
As a part of the occasion, J.D. Finley, Chief Govt Officer of Palisade Bio, will present an elevator pitch and description the Firm’s upcoming milestones. Moreover, traders and events could have the chance to submit questions stay throughout the occasion. Collaborating firms will reply as many questions as potential within the time allowed.
A stay video webcast of the presentation will likely be out there on the Occasions web page of the Buyers part of the Firm’s web site (www.palisadebio.com). A webcast replay will likely be out there two hours following the stay presentation and will likely be accessible for 90 days.
About Palisade Bio
Palisade Bio is a biopharmaceutical firm targeted on creating and advancing novel therapeutics for sufferers residing with autoimmune, inflammatory, and fibrotic ailments. The Firm believes that through the use of a focused method with its novel therapeutics it’ll remodel the therapy panorama. For extra data, please go to www.palisadebio.com.
Investor Relations Contact
JTC Staff, LLC
Jenene Thomas
833-475-8247
PALI@jtcir.com